Cryoablation Cancer Treatment in China: Evidence, Hospitals & Cost
Cryoablation is an image-guided local treatment that destroys selected tumor tissue through controlled freezing and thawing. China has active cryoablation programs, but the relevant question is not whether a hospital owns the technology — it is whether cryoablation fits the exact cancer, stage, tumor size, anatomy and treatment goal.
Quick answer: modern evidence is strongest in selected local settings such as pulmonary tumors and localized renal tumors, with additional organ-specific evidence in liver cancer. Cryoablation is not a whole-body cancer treatment and should not be presented as a universal alternative to surgery, radiation, microwave/RF ablation or systemic therapy.
✓ Local treatment ≠ systemic cancer treatment
✓ Lung, kidney and liver evidence separated
✓ Provider capability separated from efficacy
✓ No universal success-rate or cure claim
What Is Cryoablation?
Percutaneous cryoablation places one or more cryoprobes into a tumor under CT, ultrasound or other image guidance. Repeated freeze–thaw cycles create an ablation zone intended to destroy local tumor tissue.
Freeze–thaw local ablation
The treatment creates very low temperatures around the probes. The resulting ice ball is visible on imaging and helps the operator monitor the ablation zone.
Image-visible treatment margin
Because the ice ball can be visualized, the operator can monitor its relationship to the target and nearby structures during the procedure.
Local, not whole-body treatment
Cryoablation treats selected local targets. It does not automatically treat microscopic disease or metastases elsewhere in the body.
Where Is the Evidence Strongest?
Cryoablation evidence is organ-specific. A result in a small lung tumor cannot simply be transferred to pancreatic, liver, kidney or metastatic disease.
| Clinical setting | Current evidence signal | How to interpret it | Status |
|---|---|---|---|
| Primary / metastatic lung tumors | 2026 meta-analysis: 19 studies, 786 patients, 1,048 tumors; pooled 1-year local tumor control 90.5% | Meaningful local-control evidence in selected pulmonary tumors; smaller tumors performed better | Strong local signal |
| Localized renal cell carcinoma | Large systematic-review literature; 2025 meta-analysis included multiple ablative approaches | Established selected-use local treatment, particularly when surgery is unsuitable or nephron preservation matters | Established selected use |
| Hepatocellular carcinoma | Comparative meta-analyses versus microwave and radiofrequency ablation | Potential option in selected HCC; no universal survival superiority over other ablation methods | Comparative |
| Pancreatic / other tumors | More heterogeneous and often lower-certainty evidence | Requires disease-specific review; provider experience alone is not proof of benefit | Case-specific |
Evidence rule: local tumor control is not the same outcome as overall survival or cure. When a study reports local control, ParkMega keeps that endpoint labelled rather than turning it into a general survival claim.
Lung Tumors: The Clearest Recent Cryoablation Signal
Recent pulmonary evidence gives us a useful benchmark — and also shows why tumor size, protocol and complications need to be discussed explicitly.
Pooled one-year local tumor control across 19 studies involving 786 patients and 1,048 primary or metastatic lung tumors.
Meta-regression found smaller tumor size significantly associated with better local tumor control.
The same analysis reported pooled grade 3 or higher adverse events of 4.9%; pneumothorax was common and must be planned for.
Do not read 90.5% as a cure rate. It is pooled one-year local tumor control in selected study populations. It does not mean 90.5% overall survival, cancer-free survival or cure for an individual patient.
Kidney and Liver: Different Evidence, Different Decisions
Cryoablation can be a kidney-sparing option
A 2025 meta-analysis of ablative therapies in localized renal cell carcinoma reported pooled cryoablation local-control estimates of 95% at 1 year, 94% at 2 years and 90% at 5 years across included studies. A separate 2024 meta-analysis found only a small average reduction in renal function after percutaneous cryoablation.
Compare cryo with RFA and microwave, not with marketing
Recent comparative meta-analyses report broadly similar survival or recurrence outcomes in several comparisons. Some endpoints favor cryo, but the evidence does not support a blanket claim that cryo is the superior liver-ablation method.
Who May Be Worth Reviewing for Cryoablation?
Questions that make local ablation relevant
- Is there a limited number of clearly defined local targets?
- Is the lesion technically reachable with image-guided probes?
- Is surgery unsuitable, disproportionate or not preferred after specialist review?
- Would local control meaningfully change symptoms or disease management?
- Has the case been compared with radiation and other ablation techniques?
Factors that can change the plan
- Tumor size, number and exact location
- Proximity to vessels, bowel, bronchi, nerves or other critical structures
- Bleeding risk and anticoagulant use
- Lung function and pneumothorax risk for thoracic procedures
- Metastatic burden and need for systemic treatment
This is not a self-eligibility checklist. Final selection requires imaging review and disease-specific oncology input.
Cryoablation vs Microwave, RFA, IRE and SABR
The correct comparison depends on organ, tumor size, anatomy, prior treatment and treatment goal — not on which technology sounds newest.
| Method | Mechanism | Potential role | Important limitation |
|---|---|---|---|
| Cryoablation | Freeze–thaw | Selected lung, kidney, liver, bone and other local targets | Probe placement, bleeding, adjacent-organ injury and organ-specific complications |
| Microwave ablation | Thermal heating | Widely used local ablation, particularly liver and lung | Thermal injury and anatomy around critical structures matter |
| Radiofrequency ablation | Thermal heating | Long clinical history in selected local tumors | Heat-sink and lesion size/location can affect treatment |
| IRE / NanoKnife | Electrical, non-thermal | Selected anatomically difficult tumors | Indication-specific evidence; requires probe placement and cardiac precautions |
| SABR / SBRT | Focused radiation | Non-surgical local treatment in selected cancers | Dose constraints, prior radiation and nearby organs matter |
No automatic winner. A hospital should explain why cryo is preferred for this exact lesion rather than simply offering the technique it markets most heavily.
China Provider Map: Start With the Disease, Then the Technology
Fuda Cancer Hospital
FUDA continues to list cryosurgical ablation and published 2026 activity involving lung, liver, kidney and adrenal cryoablation. That confirms current program activity, not comparative survival superiority.
Major oncology / academic centers
For lung, kidney or liver cancer, a cryo proposal should be compared with disease-specific surgery, radiation, systemic therapy and alternative ablation at an appropriate high-volume center.
“We offer cryo” is only step one
Confirm the responsible department, physician, current equipment, organ-specific case volume, imaging guidance, anesthesia plan and whether the hospital will review the actual DICOM images before quoting.
How Much Does Cryoablation Cost in China?
There is no responsible single China-wide cryoablation price for every cancer. The estimate should follow imaging review because probe count, organ, anesthesia and inpatient requirements can change the bill.
Cryoprobes + guidance
Number of probes, device consumables, CT/ultrasound guidance and procedural complexity can change cost.
Anesthesia + hospital stay
General anesthesia or sedation, monitoring, room category and expected inpatient days should be itemized.
Other treatment
Systemic therapy, radiation, surgery or additional local procedures are separate decisions and separate costs.
Complications + extra care
Ask how chest drainage, bleeding management, ICU care or extended stay would be billed if required.
Cost gate: ParkMega does not publish an unverified universal cryo price. Request a written, itemized estimate after the hospital has reviewed the case.
See Cancer Treatment Cost in China and FUDA Cancer Hospital Cost.
What to Send for a Cryoablation Review
Minimum clinical packet
- Pathology report and exact diagnosis
- Current stage and metastatic sites
- Recent contrast CT / MRI / PET-CT as relevant
- DICOM imaging files when available
- Previous surgery, radiation, ablation and systemic therapy
- Relevant biomarkers and current laboratory results
Questions the center should answer
- Exact lesion size, number and relationship to critical structures
- Why cryo rather than surgery, SBRT, microwave, RFA or IRE
- Expected number and placement of cryoprobes
- Image-guidance and anesthesia plan
- Organ-specific complication plan
- How local treatment fits the systemic-treatment sequence
How ParkMega Handles a Cryoablation Case
Classify the disease
Diagnosis, stage, lesion count, anatomy, imaging and previous treatment define whether a local procedure is even relevant.
Match the evidence
We separate lung, kidney, liver and other indications instead of treating “cryoablation” as one universal evidence claim.
Verify a provider and quote
Only after treatment fit do we verify a center, current case acceptance, logistics and an itemized estimate.
Already have a cryoablation proposal?
Send the diagnosis, imaging summary and proposal. We can frame the evidence, alternatives and provider questions before travel.
Questions to Ask Before Accepting a Cryoablation Proposal
Why cryo for this lesion?
Ask what disease or anatomy feature makes cryo preferable to surgery, radiation or another ablation technique.
Who will perform it?
Confirm the responsible interventional radiologist or surgeon, department, hospital campus and current organ-specific experience.
How will the ice ball be monitored?
Ask which imaging modality will guide probe placement and how margins and nearby structures will be monitored.
What are the patient-specific complications?
For lung cases ask about pneumothorax and chest tubes; for other organs ask about bleeding and adjacent-structure injury.
What outcome is being promised?
Local control, symptom relief, progression-free survival and overall survival are different endpoints. Ask the center to name the intended one.
What is included?
Request probes, imaging, anesthesia, medicines, room, expected stay, follow-up and major exclusions in writing.
Related China Cancer Guides
Frequently Asked Questions
Direct answers about cryoablation evidence, lung and kidney tumors, hospitals, risks and cost in China.
What is cancer cryoablation?
Cryoablation is a local treatment in which image-guided probes freeze and thaw selected tumor tissue to create an ablation zone.
Is cryoablation available in China?
Yes. Chinese hospitals have active image-guided ablation programs. FUDA, for example, has documented current 2026 activity involving lung, liver, kidney and adrenal cryoablation. Current case acceptance and physician availability should still be verified.
Which cancers have the strongest cryoablation evidence?
The evidence is organ-specific. Recent literature provides meaningful selected-use evidence for pulmonary tumors and localized renal tumors, with additional comparative evidence in hepatocellular carcinoma.
How effective is cryoablation for lung tumors?
A 2026 systematic review and meta-analysis of 19 studies, 786 patients and 1,048 lung tumors reported pooled one-year local tumor control of 90.5%. That is a local-control endpoint, not a cure or overall-survival rate.
Can cryoablation treat kidney cancer?
Percutaneous cryoablation is used in selected localized renal tumors, particularly when surgery is unsuitable or kidney preservation is important. The choice still depends on tumor size, location and patient factors.
Is cryoablation better than microwave or radiofrequency ablation?
Not universally. Comparative evidence varies by organ. For liver cancer, recent meta-analyses do not establish a universal survival advantage for cryo over microwave or radiofrequency ablation.
Does cryoablation replace chemotherapy or immunotherapy?
No. Cryoablation is a local procedure. Systemic treatment may still be necessary when cancer has spread or when microscopic disease is a concern.
What are the risks of lung cryoablation?
Pneumothorax is a common procedural complication in pulmonary cryoablation. Bleeding, pain and other complications depend on lesion location, patient health and technique.
How much does cryoablation cost in China?
There is no single verified China-wide price that applies to every patient. The hospital should review imaging and provide an itemized estimate covering probes, guidance, anesthesia, stay and major exclusions.
What records should I send for a cryoablation review?
Usually pathology, current stage, recent contrast imaging, DICOM files, previous treatments, relevant biomarkers, current laboratory results and major comorbidities.
Sources and Evidence
- Pulmonary cryoablation meta-analysis (2026). 19 studies, 786 patients and 1,048 lung tumors; pooled one-year local tumor control 90.5%. PMID 41076068.
- Localized renal cell carcinoma ablation meta-analysis (2025). Comparative systematic review of SBRT, RFA, microwave and cryoablation. PMID 39922208.
- Renal function after percutaneous cryoablation (2024). Systematic review and meta-analysis of Stage I renal cell carcinoma. PMID 38914159.
- Cryoablation vs microwave ablation for HCC. Systematic review and meta-analysis. PMID 39672723.
- Cryoablation vs radiofrequency ablation for HCC (2026). Systematic review and meta-analysis; survival outcomes broadly comparable. PMID 42595456.
- FUDA Cryoablation evidence review. Current provider activity and provider-claim verification are kept separate from independent evidence. ParkMega FUDA Cryoablation guide.
Freshness note: doctor schedules, device availability, case acceptance, prices and international-patient access can change. Verify the actual hospital proposal before travel or payment.
Medical note: this page explains evidence and access. It does not diagnose cancer, recommend cryoablation for a specific patient, guarantee eligibility or replace disease-specific oncology advice.
Check the Disease and Imaging Before Choosing Cryo
Send pathology, stage, recent imaging and previous treatment. The useful output is to determine whether local ablation is a medically relevant question, which evidence applies, which China providers can review the case and what must be confirmed before travel.
✓ No cure claim✓ No automatic eligibility✓ Local-control endpoints labelled✓ Cost requested after treatment fit